Suppr超能文献

纤维蛋白胶治疗肛瘘的长期疗效:一项前瞻性研究。

Long-term results in the treatment of fistula-in-ano with fibrin glue: a prospective study.

作者信息

Maralcan Göktürk, Başkonuş Ilyas, Gökalp Avni, Borazan Ersin, Balk Ahmet

机构信息

Department of General Surgery, Gaziantep University Faculty of Medicine, Gaziantep, Turkey.

出版信息

J Korean Surg Soc. 2011 Sep;81(3):169-75. doi: 10.4174/jkss.2011.81.3.169. Epub 2011 Sep 26.

Abstract

PURPOSE

This prospective study was done to analyze the efficacy of commercial fibrin glue application in the healing of patients with fistulas-in-ano from a long-term (mean 4.5 years) research period.

METHODS

This clinical trial of forty-six patients was performed during the period from January 2004 to February 2005. Thirty-nine men and seven women were treated for a fistula-in-ano with a commercial fibrin glue application. In the operating room, the patients underwent an anorectal examination under spinal anesthesia. The external and internal fistula tract openings were then identified. The fistula tract was curetted. Fibrin glue was injected into the external fistula opening until the fibrin glue could be seen coming from the internal opening.

RESULTS

The overall initial success rate was 86.95% (40/46). Recurrence rate was 41.30% (19/46). Two patients underwent a re-application with fibrin glue and the fistulas of these patients closed. The total recurrence rate was 36.95% (17/46). The long-term overall success rate was 63.04% (29/46).

CONCLUSION

Fibrin glue application was thus found to be an easy, safe, acceptable, successful alternative treatment in the management of fistulas-in-ano. Choosing the patient correctly is very important because long (more than 4 cm) and non-ramificate fistula tracts usually close with commercial fibrin glue.

摘要

目的

本前瞻性研究旨在从长期(平均4.5年)研究期分析商用纤维蛋白胶在肛瘘患者愈合中的疗效。

方法

本临床试验于2004年1月至2005年2月期间对46例患者进行。39名男性和7名女性接受了商用纤维蛋白胶治疗肛瘘。在手术室,患者在脊髓麻醉下接受肛肠检查。然后确定外瘘口和内瘘口。刮除瘘管。将纤维蛋白胶注入外瘘口,直到能看到纤维蛋白胶从内口流出。

结果

总体初始成功率为86.95%(40/46)。复发率为41.30%(19/46)。两名患者再次应用纤维蛋白胶,这些患者的瘘管闭合。总复发率为36.95%(17/46)。长期总体成功率为63.04%(29/46)。

结论

因此,发现应用纤维蛋白胶是肛瘘治疗中一种简单、安全、可接受且成功的替代治疗方法。正确选择患者非常重要,因为长(超过4厘米)且无分支的瘘管通常可通过商用纤维蛋白胶闭合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c7/3204547/ae31e36d3d74/jkss-81-169-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验